Neil K E, Hernández F, Kendall D A, Alexander S P
Department of Physiology and Pharmacology, University of Nottingham Medical School, Queen's Medical Centre, England.
J Neurochem. 1997 Jun;68(6):2610-7. doi: 10.1046/j.1471-4159.1997.68062610.x.
In this report, we have examined the radioligand binding and second messenger signalling characteristics of beta-adrenoceptors in the guinea-pig brain. [125I]-Iodocyanopindolol ([125I]ICYP)-labelled sites in the cerebellum and cerebral cortex were of similar densities (Bmax 34 and 24 fmol x mg(-1)) and affinities (K(D) 20 and 55 pM), respectively. Analysis of competition for [125I]ICYP binding in the cerebellum was compatible with the presence of a beta2-adrenoceptor. In this tissue, isoprenaline evoked a cyclic AMP stimulation, and also potentiated cyclic GMP accumulations evoked in the presence of a nitric oxide donor, consistent with mediation via a beta2-adrenoceptor. The [125I]ICYP binding profile in the cerebral cortex did not comply with those previously described for beta-adrenoceptor subtypes, and isoprenaline failed to alter significantly cyclic AMP accumulation in the cerebral cortex, hippocampus, or neostriatum, even in the presence of forskolin or a phosphodiesterase inhibitor. Isoprenaline was also without effect on cyclic GMP accumulation or phosphoinositide turnover in the cerebral cortex. These results suggest that the guinea-pig cerebellum expresses a functional beta2-adrenoceptor coupled to cyclic AMP generation, and potentiation of cyclic GMP accumulation. However, the guinea-pig cerebral cortex displays binding sites that exhibit beta-adrenoceptor-like pharmacology but fail to show functional coupling to cyclic AMP, cyclic GMP, or phosphoinositide signalling systems.
在本报告中,我们研究了豚鼠脑中β-肾上腺素能受体的放射性配体结合及第二信使信号转导特性。小脑和大脑皮质中[125I]-碘氰吲哚洛尔([125I]ICYP)标记位点的密度(Bmax分别为34和24 fmol x mg(-1))及亲和力(K(D)分别为20和55 pM)相似。对小脑中[125I]ICYP结合竞争的分析与β2-肾上腺素能受体的存在相符。在该组织中,异丙肾上腺素可引起环磷酸腺苷(cAMP)刺激,还能增强在一氧化氮供体存在时诱发的环磷酸鸟苷(cGMP)积累,这与通过β2-肾上腺素能受体介导一致。大脑皮质中的[125I]ICYP结合谱不符合先前描述的β-肾上腺素能受体亚型的情况,即使在存在福斯高林或磷酸二酯酶抑制剂的情况下,异丙肾上腺素也未能显著改变大脑皮质、海马体或新纹状体中的cAMP积累。异丙肾上腺素对大脑皮质中的cGMP积累或磷酸肌醇代谢也无影响。这些结果表明,豚鼠小脑表达一种与cAMP生成及cGMP积累增强偶联的功能性β2-肾上腺素能受体。然而,豚鼠大脑皮质显示出具有β-肾上腺素能受体样药理学特征的结合位点,但未能表现出与cAMP、cGMP或磷酸肌醇信号系统的功能偶联。